Overexpression of Testisin,a Serine Protease Expressed by Testicular Germ Cells,in Expithelial Ovarian Tumor Cells

Abstract

Objective: In a continued effort to identify and characterized secreted proteases that are overexpressed in ovarian carcinomas, we discovered the testisin protease as such a candidate. When this discovery was originally made, no data existed in the literature or in the GenBank database that identified such a gene. Our main objective was to determine whether this gene was overexpressed exclusively in ovarian tumor tissues compared with normal ovary and whether it was expressed in any other normal tissues.

Methods: mRNA was isolated and cDNA was prepared from 34 ovarian tumors (four adenomas, three low malignant potential tumors, and 37 carcinomas) and seven normal ovaries. The testisin mRNA expression level relative to internal control, β-tubulin, was determined by Northern blot analysis and semiquantitative polymerase chain reaction (PCR).

Results: Northern blot hybridization showed that the testisin transcript was abundant in ovarian carcinoma but was not detected in normal ovary. On examination of Northern blots from normal fetal and adult tissues, only adult testis showed abundant transcripts of testisin. Semiquantitative PCR examination showed that the testisin mRNA levels in ovarian tumors of low malignant potential and in ovarian carcinomas were significantly higher than in normal ovaries (P < .01). Testisin mRNA level in ovarian carcinomas was also significantly higher than in ovarian adenomas (P < .05). Testisin overexpression rates in advanced stage (stage 2 or 3) diseases were significantly higher than that in early stage disease (stage 1) in ovarian carcinoma samples (P < .05).

Conclusions: The induction of the testisin transcript might contribute to the development, progression, and invasive or metastatic capacity of ovarian carcinomas.

Keywords

Testisin serine prottease mRNA overexpression ovarian tumor

Get full access to this article

View all access options for this article.

References

1. Anderson PA , Kjoller L , Christtensen L , Duffy MJ . The urokinase-type plasminogen activator system in cancer metastasis, a review. Int J Cancer 1997;72:1-22.

2. McCormack RT , Rittenhouse HG , Finlay JA , et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 1995;45:729-744.

3. Tanimoto H , Yan Y , Clarke J , et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 1997;57:2884-2887.

4. Tanimoto H , Underwood LJ , Shigemasa K , et al. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cell is highly overexpressed in ovarian tumor cells. Cancer 1999;86:2074-2082.

5. Underwood LJ , Tanimoto H , Wang Y , Shigemasa K , Parmley TH , O'Brien TJ . Cloning of tumor-associate differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res 1999;59:4435-4439.

6. Hooper JD , Nicol DL , Dickinson JL , et al. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lst in testicular germ cell tumors. Cancer Res 1999;59:3199-3205.

7. Shigemasa K , Hu C , West CM , et al. p21: A monitor of p53 dysfunction. Int J Gynecol Cancer 1997;7:296-303.

8. Kozak M . The scanning model for translation: An update. J Cell Biol 1989;108:229-241.

9. Perona JJ , Craik CS . Structural basis of substrate specificity in the serine proteases. Protein Sci 1995;4:337-360.

10.

10. von Heijne G . Signal sequences. The limits of variation. J Mol Biol 1985;184:99-105.

11.

11. Yu JX , Chao L , Chao J . Molecular cloning tissue specific expression, and cellular localization of human prostasin mRNA. J Biol Chem 1995;270:13483-13489.